Effectiveness of azvudine against severe outcomes among hospitalized COVID-19 patients in Xinjiang, China: a single-center, retrospective, matched cohort study

Author:

Kapar Abiden1,Xie Songsong2,Guo Zihao34,Nan Yan2,Du Yaling2,Yin Xi2,Gong Tao5,Gu Xiu6,Zhou Yang6,Lu Wenli789,Yang Aimin10,Luo Zhaohui11,Dai Jianghong1,Wang Kailu34,Zhao Shi789ORCID,Wang Kai1ORCID

Affiliation:

1. School of Public Health, Xinjiang Medical University, Urumqi, China

2. NHC Key Laboratory of Prevention and Treatment of Central Asia High Incidence Diseases, The First Affiliated Hospital of Shihezi University, Shihezi, China

3. CUHK Shenzhen Research Institute, Shenzhen, China

4. JC School of Public Health and Primary Care, Chinese University of Hong Kong, Hong Kong, China

5. Shihezi People’s Hospital, Shihezi, China

6. School of Medicine, Shihezi University, Shihezi, Xinjiang, China

7. School of Public Health, Tianjin Medical University, Tianjin, China

8. Tianjin Key Laboratory of Environment, Nutrition and Public Health, Tianjin Medical University, Tianjin, China

9. Key Laboratory of Prevention and Control of Major Diseases in the Population (MoE), Tianjin Medical University, Tianjin, China

10. Department of Medicine and Therapeutics, Chinese University of Hong Kong, Hong Kong, China

11. The Sixth Affiliated Hospital of Xinjiang Medical University, Urumqi, China

Funder

Chinese Academy of Medical Sciences

Publisher

Informa UK Limited

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3